Q15059 (BRD3_HUMAN) Homo sapiens (Human)
Bromodomain-containing protein 3 UniProtKBInterProSTRINGInteractive Modelling
726 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
41 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of human Bromodomain containing protein 3 (BRD3) in complex with hnRNPK |
Heteromer P61978; | 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of human Bromodomain containing protein 3 (BRD3) in complex with SHMT |
Heteromer P34896; | 6×EDO; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of human bromodomain containing protein 3 (BRD3) in complex with BCLTF1 |
Heteromer Q9NYF8; | 1×EDO; | ||||
| Assess | ||||||
| Peptide 4.2B in complex with BRD3.2 |
Heteromer | 1×ACE; 1×NH2; | ||||
| Assess | ||||||
| Human BRD3 bromodomain 2 in complex with a H4 peptide containing ApmTri (H4K20ApmTri) |
Heteromer P62805; | |||||
| Assess | ||||||
| Crystal structure of human Bromodomain containing protein 3 (BRD3) in complex with ILF3 |
Heteromer Q12906; | |||||
| Assess | ||||||
| BRD3 second bromodomain in complex with histone H3 acetylation at K18 |
Heteromer P68431; | 1×EDO; 1×CL; | ||||
| Assess | ||||||
| Solution NMR structures of the BRD3 ET domain in complex with a CHD4 peptide |
Heteromer Q14839; | |||||
| Assess | ||||||
| Solution NMR structure of Brd3 ET domain bound to Brg1 peptide |
Heteromer P51532; | |||||
| Assess | ||||||
| Solution NMR structure and dynamics of human Brd3 ET in complex with MLV IN CTD |
Heteromer Q8UN00; | |||||
| Assess | ||||||
| Solution NMR structure of human Brd3 ET domain |
Heteromer P03355; | |||||
| Assess | ||||||
| Solution NMR structure of human Brd3 ET complexed with NSD3(148-184) peptide |
Heteromer Q9BZ95; | |||||
| Assess | ||||||
| Co-crystal structure of human SPOP MATH domain (E47K) and human BRD3 fragment |
Heteromer O43791; | |||||
| Assess | ||||||
| Co-crystal structure of human SPOP MATH domain (M117V) and human BRD3 fragment |
Heteromer O43791; | |||||
| Assess | ||||||
| Co-crystal structure of human SPOP MATH domain (wild-type) and human BRD3 fragment |
Heteromer O43791; | |||||
| Assess | ||||||
| Co-crystal structure of human SPOP MATH domain (D140N) and human BRD3 fragment |
Heteromer O43791; | |||||
| Assess | ||||||
| BRD3-BD1 in complex with RaPID linear peptide 1xAcK.4XE (monoAcK.4xE) | homo-2-mer | 1×GOL; | ||||
| Assess | ||||||
| BRD3-BD1 in complex with RaPID linear peptide 3xAcK.1 (triAcK.1) | homo-2-mer | 2×GOL; | ||||
| Assess | ||||||
| BRD3-BD1 in complex with RaPID linear peptide 2xAcK.1 (diAcK.1) | homo-2-mer | 2×GOL; | ||||
| Assess | ||||||
| BRD3-BD1 in complex with RaPID linear peptide 2xAcK.4xE (diAcK.4xE) | homo-2-mer | 2×GOL; | ||||
| Assess | ||||||
| BRD3-BD2 in complex with the cyclic peptide 3.2_3 | homo-2-mer | |||||
| Assess | ||||||
| Crystal Structure of the first bromodomain of human BRD3 in complex with the inhibitor JQ1 | homo-2-mer | 2×JQ1; 2×IPA; | ||||
| Assess | ||||||
| Solution structure of the bromodomain from human bromodomain containing protein 3 | monomer | |||||
| Assess | ||||||
| BRD3-BD1 in complex with the cyclic peptide 3.1_3 | monomer | 1×SO4; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD3 bound to SG3-179 | monomer | 1×5W2; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of the first bromodomain (BD1) of human BRD3 bound to ERK5-IN-1 | monomer | 1×VYJ; | ||||
| Assess | ||||||
| Physachenolide C with Bromodomain (BRD3-BD1) | monomer | 1×8L6; | ||||
| Assess | ||||||
| Crystal structure of human Bromodomain containing protein 3 (BRD3) in complex with 3-bromo-1H-indaz… | monomer | 2×EDO; 1×SCN; 1×J58; | ||||
| Assess | ||||||
| Crystal structure of human Bromodomain containing protein 3 (BRD3) | monomer | 1×NA; 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of the second bromodomain (BD2) of human BRD3 bound to Ro3280 | monomer | 1×79C; | ||||
| Assess | ||||||
| Crystal structure of the second bromodomain (BD2) of human BRD3 bound to BI2536 | monomer | 1×R78; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of the second bromodomain of human BRD3 in complex with compound | monomer | 1×5D4; 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of the second bromodomain (BD2) of human BRD3 bound to ERK5-IN-1 | monomer | 1×VYJ; | ||||
| Assess | ||||||
| Crystal Structure of the second bromodomain of human BRD3 in complex with the inhibitor JQ1 | monomer | 1×JQ1; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of the Bromo domain 2 of human Bromodomain containing protein 3 (BRD3) | monomer | 1×NA; 3×EDO; | ||||
| Assess | ||||||
| Crystal structure of the second bromodomain H395R mutant of human BRD3 | monomer | 1×NO3; | ||||
| Assess | ||||||
| Second bromodomain of BRD3 liganded with BMS-536924 | monomer | 1×N6I; 2×EDO; | ||||
| Assess | ||||||
| Solution structure of the second Bromodomain from human Bromodomain-containing protein 3 | monomer | |||||
| Assess | ||||||
| Crystal structure of the second bromodomain (BD2) of human BRD3 bound to bromosporine | monomer | 1×BMF; | ||||
| Assess | ||||||
| BD2 domain of human BRD3 bound to Physachenolide C | monomer | 1×8L6; 1×CL; | ||||
| Assess | ||||||
| Solution NMR structure of human Brd3 ET domain | monomer | |||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8ov6.1.C | monomer | 0.61 | 63.10 | |||
| Assess | ||||||
| 6cui.1.A | monomer | 0.53 | 84.03 | |||
| Assess | ||||||
1 SWISS-MODEL model built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 8ov6.1.C | monomer | 0.59 | 62.85 | ||
| Assess | ||||||